NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
10/09/2024
Voltar para busca
Dado oficial do USPTO
CLINICAL DOSE OPTIMIZATION SERVICE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CLINICAL DOSE OPTIMIZATION SERVICE
ST13
US500000086901655Classe
42, 44
Pedido
86901655
Registro
5403544
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
10/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
09/02/2016
Data de registro
13/02/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/09/2024
Última transação
10/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
701
Cadastro oficial
Supplemental Register
Primeiro uso
29/11/2015
Primeiro uso no comércio
29/11/2015
Código do desenho
4
Tipo de titular
03
Localização do titular
Glenwood, IL, US
Examinador
SAUNDERS, ANDREA DAWN
Localização atual
Historical data usage
Titulares e representantes
Titulares
Landauer, Inc.
Representantes
Caldwell A. Camero Fluke Corporation
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Analyzing patient radiation dose data and preparing scientific reports providing information on optimizing imaging protocols by comparing dose performance to external benchmarks for dosimetry monitoring purposes; Analyzing patient radiation dose data and preparing scientific reports providing information on incidents where a patient dose index exceeds expected dose index ranges for dosimetry monitoring purposes; Analyzing computed tomography protocols and preparing scientific reports providing information on optimizing imaging protocols by comparing radiation dose performance to external benchmarks for medical purposes; Analyzing computed tomography protocols and preparing scientific reports providing information on incidents where a patient radiation dose index exceeds expected dose index ranges for dosimetry monitoring purposes; Consulting services in the field of monitoring the proper control and handling of radiation material to identify options for reducing radiation dosage as part of medical treatment; Consulting services in the field of radiation monitoring to optimize the radiation dose delivered to patients while preserving image clarity for optimal clinical decision making for dosimetry monitoring; Monitoring and benchmarking of radiation dose alerts for dosimetry monitoring
Classe 44
Consulting services in the field of medical imaging regarding the use and operation of computed tomography and fluoroscopy; Providing informationadvice and data on medical imaging; Consulting services in the field of radiation monitoring to optimize the radiation dose delivered to patients while preserving image clarity for optimal clinical decision making for medical dosimetry
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
10/09/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/09/2024
ES8R
TEAS SECTION 8 RECEIVED
13/02/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
13/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/03/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/03/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/03/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/03/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/05/2018
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
13/02/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/01/2018
ALIE
ASSIGNED TO LIE
26/12/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
12/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
12/12/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/12/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
12/12/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/12/2017
ZZAX
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
05/12/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/12/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
05/12/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/12/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
05/12/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/12/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/11/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/11/2017
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
23/05/2017
GPRA
PRIORITY ACTION E-MAILED
23/05/2017
CPRA
PRIORITY ACTION WRITTEN
23/05/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/04/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
26/04/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
26/04/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/12/2016
GNFR
FINAL REFUSAL E-MAILED
01/12/2016
CNFR
FINAL REFUSAL WRITTEN
01/12/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/05/2016
GNRT
NON-FINAL ACTION E-MAILED
12/05/2016
CNRT
NON-FINAL ACTION WRITTEN
12/05/2016
DOCK
ASSIGNED TO EXAMINER
12/05/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/02/2016
NWAP
NEW APPLICATION ENTERED
12/02/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CLINICAL DOSE OPTIMIZATION SERVICE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.